Targeting Na-H exchanger 1 overcomes nuclear factor kappa B-mediated tumor resistance to radiotherapy.

Authors:
Son A; Kang S; Choi S; Shin SW; Kim Y and 2 more

Journal:
Neoplasia

Publication Year: 2022

DOI:
10.1016/j.neo.2022.100862

PMCID:
PMC9761853

PMID:
36508876

Journal Information

Full Title: Neoplasia

Abbreviation: Neoplasia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest All authors have declared no conflict of interest."

Evidence found in paper:

"This work was supported by grants from the 10.13039/501100003725National Research Foundation of Korea (NRF), funded by the Korean government (NRF-2021R1F1A1062064, NRF-2021M3H9A2098572 and NRF-2018R1D1A1B07042738). Arang Son: Validation, Formal analysis, Investigation, Data curation. Seoyeong Kang: Validation, Investigation, Visualization. Suha Choi: Investigation, Formal analysis. Sung-Won Shin: Investigation, Data curation. Yeeun Kim: Investigation, Validation. Wankyu Kim: Resources, Writing – review & editing, Supervision, Funding acquisition. Changhoon Choi: Conceptualization, Writing – original draft, Writing – review & editing, Project administration, Funding acquisition."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025